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Alternative splicing is a critical determinant of
genome complexity and, by implication, is assumed
to engender proteomic diversity. This notion has not
been experimentally tested in a targeted, quantitative
manner. Here, we have developed an integrative
approach to ask whether perturbations in mRNA
splicing patterns alter the composition of the prote-
ome. We integrate RNA sequencing (RNA-seq) (to
comprehensively report intron retention, differential
transcript usage, and gene expression) with a data-
independent acquisition (DIA) method, SWATH-MS
(sequential window acquisition of all theoretical
spectra-mass spectrometry), to capture an unbi-
ased, quantitative snapshot of the impact of
constitutiveandalternativesplicingeventson thepro-
teome. Whereas intron retention is accompanied by
decreased protein abundance, alterations in differen-
tial transcript usage andgene expression alter protein
abundance proportionate to transcript levels. Our
findings illustrate how RNA splicing links isoform
expression in the human transcriptome with proteo-
mic diversity and provides a foundation for studying
perturbations associated with human diseases.INTRODUCTION
Next-generation RNA sequencing (RNA-seq) has identified alter-
native splicing of RNA transcripts as a key mechanism that may
underlie the diversification of proteins encoded in the human
genome. Such diversification may be essential for biologic
complexity, because the number of protein-coding human genes
is lower than was widely predicted before the genome sequence
wasknown (Kimet al., 2014; Lander et al., 2001). Transcripts from
95% of multi-exon human genes are alternatively spliced (Pan
et al., 2008; Wang et al., 2008). However, the extent to which
this increased genomic complexity contributes to the generation
of proteomic diversity is largely unknown. Initial efforts to assessCell Rep
This is an open access article undthe contribution of alternative splicing to proteomic composition
and diversity have focused exclusively on the identification of
proteins derived from alternatively spliced transcripts in a
steady-state system (Blakeley et al., 2010; Brosch et al., 2011;
Ezkurdia et al., 2012; Lander et al., 2001; Leoni et al., 2011; Tress
et al., 2008; Xing et al., 2011; Zhou et al., 2010). More recent
studies have incorporated expression data, such as evidence
fromRNA-seq experiments, in the interrogation of proteomic da-
tasets to reducemapping noise (Lopez-Casado et al., 2012; Ning
and Nesvizhskii, 2010; Sheynkman et al., 2013; Tanner et al.,
2007). However, none of these studies have attempted to quan-
tify thecontributionof alternative splicing toproteomicdiversity in
a systematic manner. Here, we seek to address this fundamental
biological question by asking whether selective perturbations in
RNA splicing patterns manifest as changes in the composition
of the proteome. By using this system, we have established in a
quantitative manner how changes in splicing of a subset of tran-
scripts determine differential protein expression.RESULTS AND DISCUSSION
Experimental Strategy to Study Alternative Splicing at
the Proteomic Level
We selectively perturbed RNA splicing by depleting the core
spliceosome U5 small nuclear ribonucleo protein (snRNP)
component PRPF8 and assessed subsequent transcriptomic
and proteomic changes by RNA-seq and SWATH-MS (sequen-
tial window acquisition of all theoretical spectra-mass spec-
trometry), respectively (Figure 1). This is a compelling system
because a number of studies have demonstrated the regulatory
potential of the core spliceosome machinery (Clark et al., 2002;
Papasaikas et al., 2015; Park et al., 2004; Pleiss et al., 2007;
Saltzman et al., 2011; Wickramasinghe et al., 2015). Further-
more, we have extensively experimentally validated this system
for studying splicing at the mRNA level (Wickramasinghe et al.,
2015). Thus, using DEXSeq (Anders et al., 2012), we previously
identified 3,370 transcripts with altered splicing patterns after
PRPF8 depletion (1,284 with differential exon usage, 1,449
with intron retention, 637 with both), which constitute only a
subset of all expressed protein-coding genes (13,216 genes;
expression threshold = 1 fragments per kilobase millionorts 20, 1229–1241, August 1, 2017 Crown Copyright ª 2017 1229
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Framework to Study Contribution
of Alternative Splicing to Proteomic Compo-
sition and Diversity
Experimental and analysis workflow. Top: RNA
splicing can result in generation of multiple tran-
scripts as indicated in this hypothetical example,
including different protein coding transcripts
(transcripts A–C), as well as transcripts with re-
tained introns (transcript D). Protein coding exons
are represented by solid color bars, 50 and 30 un-
translated regions are represented by white boxes,
introns are represented by black lines, and a re-
tained intron is represented by a dark red bar. We
selectively perturbed RNA splicing by depleting the
core spliceosome factor PRPF8 and used RNA-seq
to assess the transcriptomic changes (left) and
mass spectrometry to assess the effects at the
protein level (right). PRPF8 depletion can alter the
relative transcript abundance of the 4 transcripts,
resulting in differential transcript usage (DTU),
intron retention, or unchanged transcript usage.
We have defined DTU to include cases where there
is a change in transcript relative abundance be-
tween conditions. Differential gene expression
(DGE) may also result, where the relative transcript
abundances are unchanged between conditions,
but changes in expression at the gene level are
observed. We used SWATH-MS (sequential win-
dow acquisition of all theoretical spectra) to assess
the effects at the protein level, which were vali-
dated by targeted SRM (selective reaction moni-
toring). We integrated the complete proteomic
dataset based on knowledge from our RNA-seq
experiments in order to guide the peptide
assignments (bottom panel). Because peptide 2
maps uniquely to transcript B, it is assigned to
transcript B. Peptide 1 maps to multiple transcripts
in the same gene (A and C), but after PRPF8
depletion, the expression of only one of these
transcripts is changed. The change affects the
dominant expressed isoform for this gene (known
as a major transcript), hence, peptide 1 is assigned
to transcript A. In contrast, peptide 3 maps simul-
taneously to multiple differentially used transcripts
and is therefore considered ambiguous, precluding
assignment to any transcript.[FPKM]) (Wickramasinghe et al., 2015). To enable the quantifica-
tion of a large fraction of the proteome with high accuracy, we
used a recently developed data-independent acquisition (DIA)
method, SWATH mass spectrometry (SWATH-MS), which com-
bines the comprehensive proteome coverage of conventional
shotgun proteomics with the high reproducibility and quantita-
tive accuracy of targeted protein profiling based on SRM (selec-
tive reaction monitoring) (Gillet et al., 2012; Liu et al., 2013; Ro¨st
et al., 2014). Using SWATH-MS and the OpenSWATH software
(Ro¨st et al., 2014), we were able to identify and quantify 14,695
peptides (false discovery rate [FDR] 1%) across three biological1230 Cell Reports 20, 1229–1241, August 1, 2017replicates for each condition that uniquely
map to 2,805 protein-encoding Ensembl
genes. SWATH-MS yielded high repro-
ducibility between technical (averagedPearson correlation coefficient R = 0.99) and biological repli-
cates (averaged R = 0.94) (Figure S1A). Collectively, 1,542 pro-
teins display at least one peptide with altered protein expression
levels after PRPF8 depletion (Figure S1B). Functional annotation
revealed that transcripts with altered splicing patterns and pro-
teins with altered levels are enriched in the same functional cat-
egories, namely translation, RNA splicing, mitotic cell cycle, and
ubiquitination (Figure S1C). In contrast, proteins with unchanged
levels after PRPF8 depletion are not enriched in these categories
and are instead enriched for those involved in transcription and
ribosome biogenesis (Figure S1D). Thus, significant alternative
Table 1. Alternative Integration Strategies for Differently Used Transcripts and Peptides Detected by SWATH Mass Spectrometry
Transcript Set (DTU All No.) Peptide Set (No.) Initial Overlap After Assignment Correlation Coefficient (r) Agreement (%)
DTU All Transcripts and Uniquely Mapping Peptides
transcript 30 30 r 0.487 Y, 21 (70)
transcripts (452) peptides (2,974) peptides 65 65 p value 0.01688 N, 9 (30)
genes (388) genes (859) genes 30 30
DTU All Transcripts and All Peptides
transcript 158 118 r 0.274 Y, 68 (57.63)
transcripts (452) peptides (14,695) peptides 700 530 p value 0.00378 N, 50 (42.37)
genes (388) genes (2,805) genes 128 116
DTU Major Transcripts and Uniquely Mapping Peptides
transcript 27 27 r 0.498 Y, 20 (74.07)
transcripts (291) peptides (2,974) peptides 61 61 p value 0.01672 N, 7 (25.93)
genes (263) genes (859) genes 27 27
DTU Major Transcripts and All Peptides
transcript 97 77 r 0.486 Y, 56 (72.73)
transcripts (291) peptides (14,695) peptides 481 419 p value 1.97E05 N, 21 (27.27)
genes (263) genes (2,805) genes 84 75splicing events captured at the transcriptome level are function-
ally mirrored at the proteomic level.
Establishing Methods to Integrate RNA-Seq with
SWATH/SRM Mass Spectrometry
To integrate the transcriptomic and proteomic datasets, we
focused on identifying differential splicing events at the tran-
script level, which represents a major computational challenge
(Kitchen et al., 2014; Low et al., 2013; Vogel and Marcotte,
2012). Previous analyses, including our own (Figure S1), have
identified differential splicing events from an exon-centric
perspective through mapping to the genome using DEXSeq (An-
ders et al., 2012). However, this approach is limited given that
differential exon usage provides no information on transcript
expression levels, which is expected to influence protein expres-
sion. Furthermore, differentially used exons may map to many
transcripts from the same gene, making peptide assignment
difficult. To overcome these limitations, we explored a tran-
script-centric approach, which considers transcripts as whole
units, to facilitate the integration with the proteomic dataset.
We first estimated transcript expression levels with MMSEQ
(Turro et al., 2011) and then used its companion tool MMDIFF
(Turro et al., 2014) to identify both differentially expressed genes
and differentially used transcripts. Genes with differential tran-
script usage (DTU) are defined as cases where there is a change
in the transcript relative abundances between conditions (see
pie-charts in Figure 1, left panel). We identified, at high confi-
dence, 388 genes that display DTU and 2,021 genes that display
differential gene expression (DGE) following depletion of PRPF8
(Tables 1 and S3). Transcript levels of differently used transcripts
were validated by RT-PCR (see Figure 5 and Wickramasinghe
et al., 2015 for differently used mitotic transcripts) and genes
with differential expression were validated by qRT-PCR (see
Figure S5C).
We first considered the set of peptides that map uniquely to
alternatively spliced transcripts involved in DTU events, definedfrom the mRNA data. In other words, peptide expression levels
can be directly and exclusively associated with the transcripts
of interest. Using this approach, we evaluated the impact
at the protein level of the changes in splicing detected by
RNA-seq experiments, based on the correlation between fold
changes in transcript and peptide expression after PRPF8
depletion. RNA-seq fold changes were calculated from the tran-
script-level expression estimates obtained from MMSEQ. For
each transcript, the fold change represents themedian transcript
expression in PRPF8-depleted versus control small interfering
RNA (siRNA)-treated samples across 3 biological replicates.
Peptide fold changes for each transcript were calculated by first
adding up the intensities of all the peptides that mapped to that
transcript in each given biological replicate and then dividing the
median sum for PRPF8 depletion versus controls (hence result-
ing in one fold change per transcript). We observe a Spearman’s
correlation coefficient of 0.49 and a Pearson correlation
coefficient of 0.51 when comparing fold changes in RNA and
protein expression (65 peptides from 30 genes; p value =
0.0169, Spearman; p value = 0.0102, Pearson; correlation test)
(Figure 2A; Table 1). Use of an alternative strategy to determine
peptide fold changes for each transcript, whereby the fold
change for PRPF8 depletion versus controls was determined
individually for each peptide to obtain the median fold change
of all peptides that mapped to that transcript, yielded similar re-
sults (see Table S2). However, uniquely mapping peptides repre-
sent a minority of cases (2,974 out of 14,665 peptides detected
by SWATH-MS), because many peptides, due to their length
yielded from using routine trypsin digestion and the detection
range of biological mass spectrometry, are shared between tran-
script isoforms.
Integration of Complete SWATH Proteomic Dataset
To integrate the complete proteomic dataset, we devised a strat-
egy that takes advantage not only of the information from pep-
tides that map uniquely to one transcript isoform, but also fromCell Reports 20, 1229–1241, August 1, 2017 1231
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those that map to several transcripts of the same gene (Fig-
ure 2B). To do this, we used information from our RNA-seq ex-
periments to guide the peptide assignments. More specifically,
for genes with multiple isoforms, many are expressed at an
extremely low level in comparison to themost abundant isoforms
(Gonza`lez-Porta et al., 2013) (Figure 3A). Such a low level of
mRNA expression is unlikely to manifest itself as expressed pro-
tein product within the dynamic range of the mass spectrometric
method used that is 4.4 orders of magnitude (Figure 3A).
Consequently, for each gene, we considered only the most
highly expressed transcript in each condition (major transcript)
for peptide assignment, discarding cases where DTU did not
arise in one of these. Using this criterion, we identified 263 genes
whose major transcript displayed DTU (Table 1). In some cases,
the identity of the major transcript differs between conditions
(as discussed below), whereupon we determined separately
for eachmajor transcript whether there was evidence of differen-
tial usage following depletion of PRPF8. Subsequently, we used
the regions that distinguished these two transcripts to uniquely
allocate peptides (Figure 2B).
This approach yields peptide fold change information for
419 peptides corresponding to 75 genes that display DTU.
Comparing mRNA fold changes with protein expression using
this dataset yields a Spearman’s correlation coefficient of 0.49
and a Pearson correlation coefficient of 0.37 (Figure 2B; p value =
1.973 E05, Spearman; p value = 0.0015, Pearson; correlation
test) (Table 1). Importantly, this correlation coefficient is broadly
similar to that obtained with uniquely mapping peptides across
all isoforms, but using a significantly larger dataset (419 peptides
from 75 genes versus 65 peptides from 30 genes). Nevertheless,
most weakly expressed major transcripts displaying DTU are
undetectable as expressed protein product within the dynamic
range of mass spectrometry (Figure 3B). When we focus on ma-
jor transcripts and uniquely mapping peptides, we observe a
Spearman’s correlation coefficient of 0.50 and a Pearson corre-
lation coefficient of 0.52 (61 peptides from 27 genes; p value =
0.0167, Spearman; p value = 0.0117, Pearson; correlation test)
(Figure S2). In contrast, use of an alternative integration strategy
that assigns peptides to all differently used transcripts regard-
less of their expression levels resulted in an increase in the data-
set size (530 peptides corresponding to 116 genes that display
DTU) but a sharp decrease in Spearman’s correlation coefficient
to 0.27 and to 0.21 for Pearson (p value = 0.0378, Spearman;
p value = 0.0260, Pearson; correlation test) (Figure 2C; Table 1).Figure 2. Changes in Isoform Usage Manifest Themselves at the Prote
(A) Uniquely mapping peptides and SWATH-MS. Schematic indicating peptide to
comparing changes in expression of differently used transcripts (DTU) (log2 fold c
them (log2 fold change SWATH-MS) after PRPF8 depletion is shown on right. Spe
in top left corner.
(B) Major transcripts and SWATH-MS. Schematic indicating peptide to transcript
right for transcripts whose most highly expressed isoform (major transcript) chan
(C) Use of an alternative integration strategy for peptide assignment where inform
size but reduces correlation coefficient. Specifically, if a peptide maps to multiple
was changed after PRPF8 depletion, then this peptide was assigned to that partic
simultaneously to multiple differentially used transcripts were considered ambigu
expression of differently used transcripts (DTU) (log2 fold change RNA-seq) to cha
MS) after PRPF8 depletion is shown. Spearman and Pearson correlations coeffic
See also Figure S2 and Table 1.This result suggests that the inclusion of minor transcripts with
low expression levels increases noise at both themRNA and pro-
tein level, making reliable peptide assignment difficult (Figure 3).
Consequently, this indicates that usable information can be
obtained from peptides that map to more than one transcript in
the same gene only if information on transcript abundance is
considered. Taken together, these results suggest that transcript
expression levels play a dominant role in regulating protein abun-
dance, which supports the idea that differential splicing events
in minor transcripts correspond to subtle changes that do not
have a strong impact on the overall proteome, whatever their
functional outcome.
Validation Using Selective Reaction Monitoring Mass
Spectrometry
To validate our findings using a more sensitive mass spectro-
metric approach, we performed selective reaction monitoring
(SRM) on control siRNA-treated and PRPF8-depleted samples
(Figures S3A and S3B). To increase the quantitative precision,
we spiked heavy isotope-labeled peptide standards for SRM
measurement into the sample. SRM has a higher sensitivity but
a much lower analyte throughput than SWATH; hence, we were
only able to determine peptide fold change information for 53 tar-
geted peptides corresponding to 15 genes whose major tran-
scripts display DTU. ComparingmRNA fold changeswith protein
expression using this dataset yields a Spearman’s correlation
coefficient of 0.62 and a Pearson correlation coefficient of 0.59
(p value = 0.0116, Spearman; p value = 0.01663, Pearson; corre-
lation test) (Figure 4B; Table S1).When considering only peptides
that map uniquely to transcripts involved in DTU events, we
observe an increased correlation coefficient of 0.78 (0.71 for
Pearson) (35 peptides from 13 genes; p value = 0.0017,
Spearman; pvalue=0.0043,Pearson; correlation test) (Figure4A;
Table S1) and 0.73 (0.70 for Pearson) when focusing on major
transcripts and uniquely mapping peptides (33 peptides from
12 genes; p value = 0.0063, Spearman; p value = 0.00794,
Pearson; correlation test) (Figure S3C; Table S1). Collectively,
our findings demonstrate that changes in isoform usage across
the human transcriptome manifest at the proteome level.
Biological Impact of Functional mRNA Isoforms through
Proteome Diversity
Alternative splicing has the potential to vastly increase the
diversity of proteins encoded by the human genome. To assessome Level
transcript mapping for uniquely mapping peptides is shown on left. Scatterplot
hange RNA-seq) to changes in expression of the peptides that uniquely map to
arman and Pearson correlation coefficients and associated p values are shown
mapping for major transcripts is shown on left. Similar scatterplot is shown on
ges in expression after PRPF8 depletion with corresponding peptide evidence.
ation about transcript expression levels was not considered increases dataset
transcripts in the same gene, but the expression of only one of these transcripts
ular transcript regardless of its expression level. In contrast, peptides that map
ous and were not used for further analysis. A scatterplot comparing changes in
nges in expression of their corresponding peptides (log2 fold change SWATH-
ient and associated p values are shown in top left corner.
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A B
Figure 4. Validation Using Selective Reaction Monitoring Mass Spectrometry (SRM)
(A) Uniquely mapping peptides and SRM. Scatterplot comparing changes in expression of differently used transcripts (DTU) (log2 fold change RNA-seq) to
changes in expression of the peptides that uniquelymap to them (log2 fold change SRM-MS) after PRPF8 depletion. Peptide expression information was obtained
using SRM.
(B) Major transcripts and SRM. Similar scatterplot is shown for transcripts whose most highly expressed isoform (major transcript) changes in expression after
PRPF8 depletion with corresponding peptide evidence.
See also Figure S3C and Table S2.whether the changes in alternative splicing that we observe at
the protein level may have a functional impact on cellular biology,
we focused on extreme examples of alternative splicing, where
the identity of major transcripts changes across conditions.
This is termed a switch event (Gonza`lez-Porta et al., 2013) and
two examples that result in changes in protein isoform expres-
sion as determined by SWATH and SRM are shown in Figures 5
and S4 (LAP2 and hnRNPK). We focused on lamin-associated
polypeptide (LAP2), also known as thymopoietin, because its
various isoforms have been functionally characterized in detail
(Dechat et al., 1998; Somech et al., 2005). LAP2 undergoes a
switch event after PRPF8 depletion, whereby the dominant iso-
form changes from LAP2b to LAP2a, whose N-terminal region
of 187 amino acids (encoded by exons 1–3) is shared with
LAP2b (Figures 5A and S5A). Changes in protein expression of
each isoform, consistent with the change observed at the
mRNA level, were determined by SWATH-MS and validated by
SRM. Thus, one peptide shared by both isoforms did not change
in expression after PRPF8 depletion, whereas peptides uniquelyFigure 3. Peptides Encoded by Major Transcripts Are More Frequently
(A) Expression levels (log10 FPKMs [fragments per kilobase of transcript per milli
idence are indicated for Control and PRPF8-depleted samples. Only uniquely ma
condition is shown.
(B) Lowly expressed major transcripts displaying DTU are not detectable as exp
Expression levels (log10 FPKMs) for major transcripts displaying DTU with or with
One biological replicate for each condition is shown.mapping to LAP2b decreased and those to LAP2a increased
respectively (Figures 5B and S5B). These changes were
confirmed at the RNA (Figure 5C) and protein (Figure 5D) levels
using probes and antibodies that recognize each specific
isoform.
Both isoforms have different cellular locations and functions:
LAP2b localizes to the nuclear lamina and represses transcrip-
tion of p53 and nuclear factor kB (NF-kB) target genes (Dechat
et al., 1998; Somech et al., 2005), while LAP2a is localized
throughout the nuclear interior and is implicated in the structural
organization of the nucleus (Dechat et al., 1998). In unperturbed
cells, the majority of LAP2 protein localizes to the nuclear lamina,
corresponding to the LAP2b isoform (Figure 5E). Following
PRPF8 depletion, this staining pattern is reversed: less LAP2
protein is observed at the nuclear lamina, and more is observed
in the nuclear interior, corresponding to increased levels of the
LAP2a isoform (Figure 5E). Consistent with a reduction in
LAP2b levels, we observe a de-repression of direct p53 and
NF-kB transcriptional targets after PRPF8depletion (FigureS5C),Detected by SWATH-MS
on mapped reads]) of major and minor transcripts with or without peptide ev-
pping peptides were used for this analysis and one biological replicate for each
ressed protein product within dynamic range of SWATH mass spectrometry.
out peptide evidence are indicated for Control and PRPF8-depleted samples.
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A B Figure 6. Intron Retention and Differential
Gene Expression Functionally Tune the Hu-
man Proteome
(A) Intron retention reduces protein levels. Boxplot
representing the ratio of protein expression (PRPF8
depletion/Control) is shown for retained introns
(n = 270) and non-retained introns (n = 473) with
peptide evidence. p value is indicated (Wilcoxon
test).
(B) Alterations in gene expression alter protein
abundance proportionally to transcript levels. Scat-
terplot comparing changes in expression of differ-
entially expressed genes (DGE) (log2 fold change
RNA-seq) to changes in expression of the peptides
thatmap to them (log2 foldchangeSWATH-MS) after
PRPF8 depletion. Spearman’s correlation coeffi-
cient isshown in top leftcorner.Differentlyexpressed
genes whose corresponding peptides change
significantly in expression (adjusted p value < 0.1,
t test, Holm method) are indicated in red and asso-
ciated correlation coefficient is also shown in red.
See also Figure S6 and Table S3.highlighting the potential biological impact of functionally rele-
vant mRNA isoforms by the quantitative modulation of their
respective protein isoforms.
Intron Retention Reduces Protein Levels
Intron retention is a specific form of alternative splicing that is
increasingly regarded as a regulatory event that can control
gene expression (Kalyna et al., 2012; Wong et al., 2013; Yap
et al., 2012). We therefore assessed the impact of intron reten-
tion on the composition of the proteome. Recent findings have
suggested that intron retention affects transcripts from as
many as 75% of multi-exon genes (Braunschweig et al., 2014).
Transcripts with retained introns may not be translated because
they are retained in the nucleus as they are not competent for
export or may contain a premature termination codon (PTC)
that results in their degradation by the nonsense-mediated
decay (NMD) pathway. Consistent with this hypothesis, intron
retention leading to NMD has a significant impact on transcript
levels (Braunschweig et al., 2014). However, the effect of re-
tained introns on protein expression has not been examined to
date using a systematic approach covering the transcriptome.
Following PRPF8 depletion, we see an increase in the expression
levels of intronic reads throughout the genome (p value < 2.2 3
1016) (Wickramasinghe et al., 2015). We obtained peptide evi-Figure 5. Biological Impact of Functional mRNA Isoforms
(A) Transcript representation of LAP2 isoforms and starplots of transcript relative
replicate is shown.
(B) LAP2 switch event with corresponding peptide evidence. Column plots show
columns) after PRPF8 depletion. A negative fold change is represented in yellow (L
by SWATH or SRM is shown individually, and the region of the transcript to whic
(C and D) Changes in LAP2 isoform expression are confirmed at the RNA (C) an
isoform.
(E) LAP2 isoform localization is altered after PRPF8 depletion. Immunofluorescenc
depleted Cal51 cells using antibodies that recognize each specific isoform and b
intensity is also shown with the scanning axes indicated by white lines. Pairs of n
ImageJ (NIH). Experiments in (C)–(E) were replicated independently 3 times and
See also Figures S4 and S5.dence for 270 genes that display retained introns (identified
using DEXSeq [Anders et al., 2012], see the Experimental Pro-
cedures) following PRPF8 depletion and asked whether protein
expression is downregulated in these genes compared to those
without intron retention. We find that the expression of their en-
coded proteins is reduced in comparison to those that do not
display retained introns (n = 473, p value = 0.0041, Wilcoxon
test) (Figure 6A). Furthermore, the proportion of downregulated
proteins is higher in the group of genes with retained introns
compared to those without intron retention (161/270 versus
231/473; p value = 0.0048, odds ratio: 1.547).
The relative abundance of protein-coding transcripts for each
gene also has a significant effect on protein expression. Indeed,
when considering genes with at least one transcript displaying a
retained intron biotype, the encoded proteins that are downregu-
lated after PRPF8 depletion have a higher relative abundance of
transcripts that are not protein-coding (i.e., display intron reten-
tion) for each gene in comparison to those whose proteins are
upregulated (p value = 0.0098) (Figure S6A). One example is
shown in Figures S4C and S4D, where the dominant protein-
coding isoform downregulated after PRPF8 depletion is re-
placed by an isoform with a retained intron, resulting in a
decrease in protein expression (according to 5 peptides de-
tected by SWATH-MS with average PRPF8 depletion/controlabundance in control siRNA-treated and PRPF8-depleted cells. One biological
fold change in expression of transcripts (left two columns) and peptides (right
AP2b), and a positive fold change in turquoise (LAP2a). Each peptide detected
h it maps is represented in (A) by different colored ovals.
d protein (D) levels using probes and antibodies that recognize each specific
e of LAP2b and LAP2a isoforms is shown in control siRNA-treated and PRPF8-
oth isoforms respectively (scale bar, 5 mm). Scanning analysis of LAP2 isoform
uclei of same scan width as determined by DAPI were used for scanning using
one representative experiment is shown.
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fold change of 0.575, p value = 0.018). Interestingly, for some
genes with intron retention after PRPF8 depletion, their corre-
sponding protein expression levels are unchanged or even
increased. This suggests a complex model whereby compensa-
tionmechanismsmay be at play. However, themere detection of
a transcript with a retained intron bio-type by RNA-seq may not
affect the levels of the protein encoded by that gene, unless it is
expressed at a robust level. Indeed, for those proteins that are
upregulated after PRPF8 depletion, the median protein coding
transcript relative abundance is >0.9 (Figure S6). In other words,
<10% of the transcripts that make up that gene display intron
retention, which may explain why these transcripts have no
effect on protein level. Collectively, these results suggest that
intron retention functionally tunes the human proteome as well
as the transcriptome.
Alterations in Gene Expression Alter Protein Abundance
Proportionally to Transcript Levels
Protein abundance is a direct determinant of cellular function
and is heavily influenced by transcript levels. However, the quan-
titative contribution of mRNA abundance to protein abundance
remains controversial (Cheng et al., 2016; Jovanovic et al.,
2015; Kristensen et al., 2013; Li et al., 2014; Liu et al., 2016; Ro-
bles et al., 2014; Schwanha¨usser et al., 2011; Vogel et al., 2010;
Vogel and Marcotte, 2012). Given that steady-state mRNA and
protein abundance are controlled by a number of post-transcrip-
tional and translational regulatory processes (Vogel and Mar-
cotte, 2012), establishing a correlation between the transcrip-
tome and the proteome is not straightforward. A number of
studies have used advances in next-generation sequencing
and proteomics to examine the correlation between mRNA and
protein abundances under steady-state conditions. Generally,
the results have indicated that although there is a strong correla-
tion between mRNA and protein abundance, a substantial pro-
portion of the variation in protein abundance cannot be attrib-
uted to mRNA expression alone (Fu et al., 2009; Ghazalpour
et al., 2011; Lundberg et al., 2010; Nagaraj et al., 2011; Schwan-
ha¨usser et al., 2011). This may be due to technical or experi-
mental noise, along with limitations of the timescale in the exper-
imental design and data modeling approaches (Liu et al., 2016).
In contrast, more recent studies using advanced technical mea-
surements in both steady-state and perturbed conditions have
suggested that changes in mRNA abundance play a dominant
role in determining the majority of dynamic changes in protein
levels (Jovanovic et al., 2015; Robles et al., 2014), although
this may depend on the respective contributions of mRNA and
protein level regulation to the biological system being studied
(Cheng et al., 2016).
We determined the contribution of changes in mRNA abun-
dance to protein abundance using our biological system of per-
turbed RNA splicing. We observe 2,021 genes that are differen-
tially expressed (DGE) after PRPF8 depletion and obtained fold
change information for 3,057 peptides corresponding to 572
genes that display DGE (Table S3). We observed a Spearman’s
correlation coefficient of 0.63 when comparing RNA and protein
fold changes in expression (Figure 6B; Table S3) that increases
to 0.79 when focusing on peptides with a significant fold change
(adjusted p value < 0.1, t test, Holm method) (Figure 6B; Table1238 Cell Reports 20, 1229–1241, August 1, 2017S3). A correlation coefficient of 0.58 (increasing to 0.76 when
considering peptides with significant fold change, adjusted
p value <0.1, t test, Holm method) is observed when focusing
on uniquely mapping peptides (Figure S6B). Importantly, when
we focus on the genes that do not display DGE, we observe a
correlation coefficient of 0.29 when comparing RNA and protein
fold changes in expression (Figures S6C and S6D), suggesting
that changes in gene expression are driving the changes in pro-
tein expression. Taken together, these results suggest that in a
system with perturbed alternative splicing, a significant propor-
tion of the variation in protein abundance can be chiefly attrib-
uted to changes in mRNA levels.
In summary, our results illustrate how RNA splicing links iso-
form expression in the human transcriptome with proteomic di-
versity. We further show that alternative splicing events causing
intron retention are accompanied by decreased protein abun-
dance, whereas alterations in differential transcript usage and
gene expression alter protein abundance proportionally to tran-
script levels. The fraction of the whole proteome mass of a hu-
man cell represented by the number of proteins identified in
our study is very high (>99.5%) (Beck et al., 2011), suggesting
that the observed events are likely to be representative for the
proteome.
Our integrative analysis using a perturbed system suggests
that alternative splicing events significantly contribute to both
proteomic composition and diversity in humans. While a recent
study that used ribosome occupancy as an indicator of transla-
tion output and not protein levels, supports our conclusions
(Weatheritt et al., 2016), the contribution of alternative splicing
to proteomic complexity remains divisive (Blencowe, 2017;
Tress et al., 2017a, 2017b). The increase in correlation coefficient
between mRNA and protein levels that we observe from SWATH
to SRM suggests that a significant proportion of the protein vari-
ance from our perturbed system can be explained by differences
in isoform usage. Critically, this depends on both the sensitivity
of the mass spectrometric method used and the identification
of high confidence alternative splicing events at the transcript
level.
The methods we have developed to integrate RNA-seq and
quantitative SWATH and SRM mass spectrometry data to study
splicing demonstrate that usable information can be obtained
from peptides that map to more than one transcript in the
same gene once information on transcript abundance is consid-
ered. They provide a foundation for future studies to examine the
proteome-wide effects of altered RNA splicing associated with
human diseases (Kurtovic-Kozaric et al., 2015; Quesada et al.,
2011; Tanackovic et al., 2011; Yoshida et al., 2011).EXPERIMENTAL PROCEDURES
Analysis of RNA-Seq Data
The transcriptome of control siRNA-treated and PRPF8-depleted Cal51 cells
was sequenced on an Illumina HiSeq2000 platform using 100 bp paired-end
reads with poly(A)+RNA isolated from 3 and 4 independent experiments,
respectively, as previously described (Wickramasinghe et al., 2015). Raw
reads were directly mapped to the transcriptome with Bowtie v0.12.7 (Lang-
mead et al., 2009), using Ensembl v66 as a reference (Flicek et al., 2012).
Following the estimation of transcript expression levels with MMSEQ v1.0.7
(Turro et al., 2011), its companion tool MMDIFF (Turro et al., 2014) was used
to identify both differentially expressed genes and differentially used
transcripts as described in more detail in the Supplemental Experimental
Procedures.
Protein Extraction and In-Solution Digestion
The cell pellets from three independent depletion experiments (control siRNA
and PRPF8-depleted) were lysed on ice by using a lysis buffer containing 8 M
urea (EuroBio), 40 mM Tris-base (Sigma-Aldrich), 10 mM DTT (AppliChem),
and complete protease inhibitor cocktail (Roche) as described in more detail
in the Supplemental Experimental Procedures.
Shotgun and SWATH-MS Measurement
The peptides digested from Cal51 lysate were all measured on an AB Sciex
5600 TripleTOF mass spectrometer operated in DDA mode. The same liquid
chromatography-tandem mass spectrometry (LC-MS/MS) system used for
DDA measurements was also used for SWATH analysis (Collins et al., 2013;
Gillet et al., 2012; Liu et al., 2013) and is described in more detail in the Supple-
mental Experimental Procedures.
Assignment of Peptides to Transcripts
An initial set of 16,779 peptides was detected across biological replicates
for each condition (control siRNA and PRPF8-depleted samples) using
SWATH-MS and mapped against all the protein coding transcripts annotated
in Ensembl v66, including those with a nonsense-mediated decay biotype.
Removal of peptides that mapped to more than one gene led to a set of
14,695 peptides (corresponding to 2,805 genes), which was used for down-
stream analysis. Peptides were assigned to specific transcripts as outlined
in Figure 1. Peptides that map uniquely to each transcript represented aminor-
ity of events (2,974 peptides mapping to 859 genes). Peptides that map ubiq-
uitously to several transcripts of the same gene were assigned based on
knowledge from the RNA-seq experiments using the following criteria. Two
alternative peptide assignment strategies were considered. One strategy
incorporated information on transcript isoform abundance for each gene into
our analysis, whereby only peptides that map to major transcripts were
considered. Major transcripts are the dominant expressed isoform for each
gene and those identified as major in either control siRNA-treated or PRPF8-
depleted samples were used specifically for peptide assignment. Additionally,
we considered an alternative assignment strategy where information about
transcript expression levels was not considered. Specifically, if a peptide
maps to multiple transcripts in the same gene, but the expression of only
one of these transcripts was changed after PRPF8 depletion, then this peptide
was assigned to that particular transcript regardless of its expression level. In
contrast, peptides that map simultaneously to multiple differentially used tran-
scripts were considered ambiguous and were not used for further analysis.
Integration of Transcriptomic and Proteomic Data
To integrate transcriptomic and proteomic data, fold changes in transcript
and peptide expression after PRPF8 depletion were obtained from RNA-seq
and SWATH or SRM mass spectrometry experiments, respectively. RNA-
seq fold changes were calculated from the transcript-level expression esti-
mates obtained from MMSEQ as described above. For each transcript, the
fold change represents the median transcript expression in PRPF8-depleted
versus control siRNA-treated samples.
Raw peptide intensities were first quantile-normalized in order to enable
comparison across samples. For each peptide, the observed intensities
across the biological replicates in each condition were summarized by using
the median, and a fold change was obtained by dividing the value obtained
for PRPF8-depleted and control siRNA-treated samples. Peptide fold changes
for each transcript were calculated by first adding up the intensities of all
the peptides that mapped to that transcript in each given biological replicate
and then dividing the median value of the summed peptide signals for
PRPF8 depletion versus controls (hence resulting in one fold change per tran-
script). The same analysis was used for both SWATH and SRM datasets. Use
of an alternative strategy to determine peptide fold changes for each tran-
script, whereby the fold change for PRPF8 depletion versus controls was
determined individually for each peptide to obtain the median fold change of
all peptides that mapped to that transcript, yielded similar results (see TableS2). The fold changes derived from these two technologies were integrated
as described in Figure 1. Spearman correlation was used to evaluate the rela-
tionship between transcript and peptide fold changes, as previously sug-
gested (Maier et al., 2009). We also used Pearson correlation as a comparison.
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